These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30361178)

  • 1. [Update from France Macula Federation: Treatment of Wet AMD].
    Tick S; Cornut PL; De Bats F; Wolf B; Souied EH; Cohen SY
    J Fr Ophtalmol; 2018 Nov; 41(9):862-867. PubMed ID: 30361178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Update from France Macula Federation: Diagnosis of wet AMD].
    Wolff B; De Bats F; Tick S; Cornut PL; Souied É; Cohen SY
    J Fr Ophtalmol; 2018 Nov; 41(9):857-861. PubMed ID: 30348597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of wet AMD in France in 2015].
    Zerbib J; Bourhis A; Cornut PL; De Bats F; Grenet T; Gualino V; Halfon J; Massé H; Srour M; Streho M; Tick S; Wolff B; San Nicolas N
    J Fr Ophtalmol; 2017 Nov; 40(9):723-730. PubMed ID: 29055730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration.
    Veloso CE; Kanadani TM; Pereira FB; Nehemy MB
    Ophthalmology; 2015 Aug; 122(8):1569-72. PubMed ID: 26038338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD.
    Waizel M; Todorova MG; Masyk M; Wolf K; Rickmann A; Helaiwa K; Blanke BR; Szurman P
    BMC Ophthalmol; 2017 May; 17(1):79. PubMed ID: 28535756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year functional and anatomical results after converting treatment resistant eyes with exudative age-related macular degeneration to aflibercept in accordance with a treat and extend protocol.
    Jørstad ØK; Faber RT; Moe MC
    Acta Ophthalmol; 2017 Aug; 95(5):460-463. PubMed ID: 28556485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAVE-AMD: Safety of VEGF Inhibitors in Age-Related Macular Degeneration.
    Enseleit F; Michels S; Sudano I; Stahel M; Zweifel S; Schlager O; Becker M; Winnik S; Nägele M; Flammer AJ; Neidhart M; Graf N; Matter CM; Seifert B; Lüscher TF; Ruschitzka F
    Ophthalmologica; 2017; 238(4):205-216. PubMed ID: 28866675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis.
    Ba J; Peng RS; Xu D; Li YH; Shi H; Wang Q; Yu J
    Drug Des Devel Ther; 2015; 9():5397-405. PubMed ID: 26451092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change of retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in exudative age-related macular degeneration.
    Kim M; Kim ES; Seo KH; Yu SY; Kwak HW
    Indian J Ophthalmol; 2016 Jun; 64(6):427-33. PubMed ID: 27488150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB.
    Avery RL; Castellarin AA; Steinle NC; Dhoot DS; Pieramici DJ; See R; Couvillion S; Nasir MA; Rabena MD; Maia M; Van Everen S; Le K; Hanley WD
    Retina; 2017 Oct; 37(10):1847-1858. PubMed ID: 28106709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Real life visual and anatomic outcomes of aflibercept treatment for treatment-naive patients with exudative age-related macular degeneration].
    Duval MV; Rougier MB; Delyfer MN; Combillet F; Korobelnik JF
    J Fr Ophtalmol; 2017 Apr; 40(4):270-278. PubMed ID: 28341388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment
    Witkin AJ; Rayess N; Garg SJ; Maguire JI; Storey P; Kaiser RS; Hsu J; Vander JF; Ho AC
    Semin Ophthalmol; 2017; 32(3):309-315. PubMed ID: 26337539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gas-mediated vitreomacular adhesion release with intravitral ranibizumab injections for exudative age-related macular degeneration.
    Kang HM; Lee SJ; Kim CG; Chung EJ; Koh HJ
    Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1681-92. PubMed ID: 26743753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of Inflammatory Factors in Aqueous Humor during Ranibizumab or Aflibercept Treatment for Age-Related Macular Degeneration.
    Motohashi R; Noma H; Yasuda K; Kotake O; Goto H; Shimura M
    Ophthalmic Res; 2017; 58(4):209-216. PubMed ID: 28796997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHANGES IN PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR LEVEL AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB, AFLIBERCEPT, OR RANIBIZUMAB FOR DIABETIC MACULAR EDEMA.
    Hirano T; Toriyama Y; Iesato Y; Imai A; Murata T
    Retina; 2018 Sep; 38(9):1801-1808. PubMed ID: 29280940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aflibercept administration in neovascular age-related macular degeneration refractory to previous anti-vascular endothelial growth factor drugs: a critical review and new possible approaches to move forward.
    Lazzeri S; Ripandelli G; Sartini MS; Parravano M; Varano M; Nardi M; Di Desidero T; Orlandi P; Bocci G
    Angiogenesis; 2015 Oct; 18(4):397-432. PubMed ID: 26346237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of outer retinal tubulations in eyes switched from intravitreal ranibizumab to aflibercept for treatment of exudative age-related macular degeneration.
    Massamba N; Dirani A; Butel N; Fardeau C; Bodaghi B; Ingram A; Lehoang P
    Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):61-67. PubMed ID: 27397583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-Term Outcome in Patients with Intravitreal Anti-VEGF Therapy for Exudative AMD].
    Amstutz CA; Fleischhauer J; Zweifel S; Barthelmes D
    Klin Monbl Augenheilkd; 2015 Apr; 232(4):533-7. PubMed ID: 25902115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Overview of medical practices in wet AMD in France].
    Massé H; Wolff B; Bonnabel A; Bourhis A; Cornut PL; De Bats F; Gualino V; Halfon J; Koehrer P; Souteyrand G; Streho M; Tick S; Zerbib J; Chartier C
    J Fr Ophtalmol; 2016 Jan; 39(1):40-7. PubMed ID: 26747017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of anti-VEGF therapies on fibrovascular pigment epithelial detachments in age-related macular degeneration.
    Au A; Parikh VS; Singh RP; Ehlers JP; Yuan A; Rachitskaya AV; Sears JE; Srivastava SK; Kaiser PK; Schachat AP; Martin DF; Modi Y
    Br J Ophthalmol; 2017 Jul; 101(7):970-975. PubMed ID: 27913442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.